v3.25.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Statement of Financial Position [Abstract]    
Accounts Receivable, Allowance for Credit Loss, Current $ 54 $ 52
Allowance for Credit Loss, Receivable, Other, Current 2 0
Accumulated depreciation (9,311) (8,701)
Finite-Lived Intangible Assets, Accumulated Amortization 472 426
Other Noncurrent Assets, Allowance $ 22 $ 20
Common stock, shares authorized (in shares) 1,200,000,000 1,200,000,000
Common Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares issued (in shares) 859,711,007 859,709,987
Common stock, shares outstanding (in shares) 711,922,815 711,074,269
Variable Interest Entity [Line Items]    
Loans Receivable, Fair Value Disclosure $ 800 $ 0
Financing Receivable, Loan in Process $ 20 $ 0